Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

Anti-E

Testing red cell samples with anti-C, anti-D, and anti-E, anti-c and anti-e will disclose the Rh phenotype from which the most probable genotype may be deduced. Knowing the probable paternal genotype can be of value in the management of RhD hemolytic disease of the foetus and new-born where R2infants are likely to be more severely affected than are R1r infants.

The BiorexAnti-E Diagnostics Anti-E reagent is for the in vitro detection and identification of the human E blood group antigen by direct agglutination.

Add to Quote

Description

Product Name CAT.No Size
Anti-E BGBE0005 1 x 5ml
Anti-e (Monoclonal) BGLE0005 1 x 5ml

 

 

Product Description

The Biorex Diagnostics Anti-E reagent is a ready-to-use solution for the accurate detection of the E antigen within the Rh blood group system. It provides reliable and reproducible RhE typing, supporting safe transfusions, extended Rh phenotyping, and the prevention of haemolytic transfusion reactions (HTRs) and haemolytic disease of the foetus and newborn (HDFN).

Key Features
• Reliable E antigen detection – identifies presence or absence of the E antigen on red blood cells
• Direct agglutination principle – clear and interpretable results for clinical use
• Clinical relevance – supports safe transfusions and HDFN prevention
• Comprehensive Rh phenotyping – used with Anti-C, Anti-D, Anti-c, and Anti-e for full Rh antigen typing
• Ready-to-use format – stable liquid formulation requiring no dilution or preparation

Benefits
The Anti-E reagent allows laboratories to perform accurate Rh phenotyping for patients and donors, supporting transfusion compatibility, antenatal care, and complex antibody identification. Its ready-to-use format and reproducible performance streamline workflow, reduce errors, and enhance patient safety in clinical and transfusion laboratories.

Applications
• Routine blood grouping – determination of RhE phenotype in donors and patients
• Transfusion medicine – ensures antigen compatibility and reduces alloimmunisation risk
• Antenatal care – detects maternal–foetal Rh incompatibility for early HDFN intervention
• Reference and specialist laboratories – supports extended Rh typing and complex immunohaematology studies

Additional information

Storage

2-8°C